Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Century Therapeutics Inc (IPSC)

97 + Investors. Track Smart Money conviction in IPSC. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +27
Streak
2Q ▲
Buyers last Q
74%

Smart Money Signals — IPSC

Based on 99 hedge funds · latest filing: 2026 Q2 · updated quarterly

📈

Buying streak — 2 quarters in a row

last 6Q
For 2 consecutive quarters, more hedge funds added IPSC than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🏔️

At the ownership peak (100% of max)

100% of all-time peak
99 hedge funds hold IPSC right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
🚀

Fast accumulation — +52% more funds vs a year ago

fund count last 6Q
+34 new funds entered over the past year (+52% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks. The peak was reached in just 2 quarters from the low — a sharp move.
🟢

More buyers than sellers — 74% buying

68 buying24 selling
Last quarter: 68 funds were net buyers (38 opened a brand new position + 30 added to an existing one). Only 24 were sellers (13 trimmed + 11 sold completely). A clear majority buying is a strong confirmation signal.
📈

More new buyers each quarter (+7 vs last Q)

new funds entering per quarter
Funds opening a new IPSC position: 4 → 9 → 31 → 38. A growing influx of new institutional buyers means the asset is still gathering momentum — the consensus hasn't fully saturated yet.
🔒

41% of holders stayed for 2+ years

■ 41% conviction (2yr+) ■ 23% medium ■ 35% new
41 out of 99 hedge funds have held IPSC for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
🚀

Acceleration phase — new buyers rushing in

21 → 4 → 9 → 31 → 38 new funds/Q
New funds entering each quarter: 4 → 9 → 31 → 38. The pace of institutional discovery is accelerating sharply. This is the 'hot idea' phase — the thesis is being passed from fund to fund. You are not late — the accumulation wave is still building.
🏛️

Veteran-anchored — 54% veterans vs 34% newcomers

■ 54% veterans ■ 12% 1-2yr ■ 34% new
Entry-cohort mix of 102 holders: 55 (54%) are 2+ year veterans, 12 entered 1–2 years ago, and 35 (34%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.
📋

Smaller funds dominant — 16% AUM from top-100

16% from top-100 AUM funds
33 of 98 holders rank in the top 100 by AUM, but together hold only 16% of total institutional value. The stock is held primarily by smaller and mid-sized funds.
5.0
out of 10
Moderate Exit Risk
Exit risk score 5.0/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — IPSC

In 2026 Q2, 68 hedge funds were net buyers of IPSC (38 opened a new position, 30 added to an existing one), while 24 reduced or exited (13 trimmed, 11 sold completely) — a 74% buyer ratio, indicating clear institutional accumulation. Net buying has persisted for two consecutive quarters, a positive momentum signal. Net fund flow last quarter: +27 funds (more new holders than closures). Total institutional holders: 99.

Hedge Fund Ownership: IPSC

How many hedge funds hold IPSC — quarterly history vs. share price
Quarterly hedge fund ownership of IPSC vs. share price

Market Analysis: IPSC

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: IPSC

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Century Therapeutics Inc (IPSC) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much IPSC has moved relative to its sector benchmark (XLV) since the 2026 Q2 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End June 30, 2026 · 61d ago
IPSC
-17.3%
XLV
+8.7%

IPSC outperformed XLV by -26.0% since June 30, 2026.

Since 13F Filing Date August 14, 2026 · 16d ago
IPSC
+5.5%
XLV
+16.4%

Since the filing became public, IPSC outperformed XLV by -10.9% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

9 top-rated funds 0 high-conviction
Consensus
4.3
/ 10
breadth
×
Elite
2.0
/ 10
conviction
Hedge Fund Positioning: IPSC
97 + Investors

Track Smart Money conviction in IPSC. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q2) Prior (2026 Q1) Change
Funds Holding 97 72 34.72%
13F Shares 158M 139M 14.19%
Total Value $387M $310M 24.95%
New Positions 37 31 +6
Increased Positions 30 15 +15
Closed Positions 11 5 +6
Reduced Positions 12 12 -
Total Calls 2 2 -
Total Puts 2 0 100%
PUT/CALL Ratio 1.0 0.0 Neutral

Statistics: IPSC

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q2)

97 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in IPSC. Verified SEC 13F-HR filings.

QUARTER:
Top 25 IPSC holders by conviction (% of portfolio weight) — 2026 Q2 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Versant Venture Management, LLC 18.33% 12,166,109 $29.8M
2 Spruce Street Capital LP 1.95% 4,059,054 $9.9M
3 Seven Fleet Capital Management LP 1.76% 4,347,826 $10.7M
4 Trails Edge Capital Partners, LP 1.61% 4,134,969 $10.1M
5 Commodore Capital LP 1.27% 8,695,652 $21.3M
6 DAFNA Capital Management LLC 1.12% 2,400,458 $5.9M
7 TCG Crossover Management, LLC 1.04% 17,754,430 $43.4M
8 Stempoint Capital LP 0.91% 2,146,182 $5.3M
9 Venrock Adviser, LLC 0.65% 8,695,652 $21.3M
10 Ra Capital Management, L.P. 0.38% 17,754,430 $43.5M
11 Deep Track Capital, LP 0.34% 9,462,645 $23.2M
12 Spark Investment Management LLC 0.28% 59,000 $145K
13 Rtw Investments, LP 0.18% 8,695,652 $21.3M
14 Rock Springs Capital Management LP 0.16% 1,304,347 $3.2M
15 Casdin Capital, LLC 0.15% 1,228,190 $3.0M
16 DV Trading LLC 0.11% 1,400,000 $3.4M
17 Verdad Advisers, LP 0.11% 46,200 $113K
18 Parametrica Management Ltd 0.05% 27,840 $68K
19 Harbourvest Partners LLC 0.04% 29,018 $71K
20 Woodline Partners LP 0.03% 4,257,530 $10.4M
21 Balyasny Asset Management L.P. 0.02% 5,522,944 $13.5M
22 Axq Capital, LP 0.02% 59,056 $145K
23 Point72 Asset Management, L.P. 0.01% 4,980,526 $12.2M
24 Adage Capital Partners GP, L.L.C. 0.01% 3,789,538 $9.3M
25 Quadrant Private Wealth Management, LLC 0.01% 20,022 $49K
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Century Therapeutics Inc (IPSC)

What does the Smart Money Trend signal show for IPSC?

Buying streak — 2 quarters in a row: For 2 consecutive quarters, more hedge funds added IPSC than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for IPSC?

More buyers than sellers — 74% buying: Last quarter: 68 funds were net buyers (38 opened a brand new position + 30 added to an existing one). Only 24 were sellers (13 trimmed + 11 sold completely). A clear majority buying is a strong confirmation signal.

What is the fund quality score for IPSC holders?

Smaller funds dominant — 16% AUM from top-100: 33 of 98 holders rank in the top 100 by AUM, but together hold only 16% of total institutional value. The stock is held primarily by smaller and mid-sized funds.

How long have hedge funds held IPSC?

41% of holders stayed for 2+ years: 41 out of 99 hedge funds have held IPSC for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Is it too late to buy Century Therapeutics Inc (IPSC) following the 2026 Q2 hedge fund 13F filings?

As of today, IPSC has moved +5.5% since the 2026 Q2 13F filing date (August 14, 2026), compared to +16.4% for the XLV sector ETF — an outperformance of -10.9%. Since the quarter end (June 30, 2026), IPSC has gained -17.3% vs +8.7% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →